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STATE-OF-THE-ART REVIEW

Cardiac Lymphatic Vessels, Transport,
and Healing of the Infarcted Heart
Li-Hao Huang, PHD,a Kory J. Lavine, MD, PHD,b Gwendalyn J. Randolph, PHDa

SUMMARY
The lymphatic vasculature plays a key role in regulating tissue ﬂuid homeostasis, lipid transport, and immune surveillance
throughout the body. Although it has been appreciated that the heart relies on lymphatic vessels to maintain ﬂuid balance and
that such balance must be tightly maintained to allow for normal cardiac output, it has only recently come to light that the
lymphatic vasculature may serve as a therapeutic target with which to promote optimal healing following myocardial ischemia
and infarction. This article reviews the subject of cardiac lymphatic vessels and highlights studies that imply targeting of
lymphatic vessel development or transport using vascular endothelial growth factor-C therapy may serve as a promising
avenue for future clinical application in the context of ischemic injury. (J Am Coll Cardiol Basic Trans Science 2017;2:477–83)
© 2017 Washington University School of Medicine. Published by Elsevier on behalf of the American College of Cardiology
Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

H

ippocrates (460 to 370 BC) ﬁrst described the

vessels in the meningeal membranes around the brain

colorless vessels that are now recognized as

have only recently been discovered, where they func-

comprising

tion to facilitate immune cell and cerebral interstitial

the

lymphatic

vasculature;

however, few studies focused on these specialized

ﬂuid drainage from the brain (6–9). In the eye, a

vessels in the ensuing 2,000-year period (1). Histori-

specialized structure referred to as Schlemm’s canal

cally, the reason why this research has evolved so

bears features of lymphatic vessels and regulates

slowly is due to the technical difﬁculty in visualizing

intraocular pressure (7,9,10). Novel functions of the

the colorless lymphatic vasculature. In the early 20th

lymphatic vasculature have also recently emerged,

century, Florence Sabin injected ink into pig embryos

including a key role in preparing the developing lung

and discovered that lymphatic vessels originated

for inﬂation at birth to avoid respiratory neonatal fail-

from out-sprouting of existing veins during develop-

ure (11). Progress has also been made in deﬁning a role

ment (2). Not until the end of the 20th century, when

for lymphatic vessels in transporting cholesterol from

the lymphatic vasculature could be speciﬁcally visual-

the artery wall to reduce risk of atherosclerosis. We

ized through the discovery of key genes that faithfully

have recently reviewed this subject, but we will not

marked lymphatic endothelial cells, was it possible to

discuss it here (12).

truly observe and appreciate lymphatic anatomy (3–

Progress in lymphatic vessel research has also

5). For this reason, the very presence of lymphatic ves-

emerged in the heart. This review focuses on the

sels in some anatomic locations is still being described.

current understanding of cardiac lymphatic biology.

For instance, in the central nervous system, lymphatic

First, we describe the origin of the cardiac lymphatic
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ABBREVIATIONS

vasculature during development and then

agree on the derivation of at least part of the intes-

AND ACRONYMS

review overall cardiac lymphatic anatomy

tinal lymphatic vasculature from nonvenous, local

and function. Finally, we discuss the poten-

sources. These origins depend upon the prior forma-

endothelial hyaluronan

tial of therapeutic strategies to target cardiac

tion of arteries (20) and appear to descend from

receptor 1

lymphatic vasculature.

hemogenic endothelium (21), a subset of endothelial

LYVE1 = lymphatic vessel

PDGFRb = platelet-derived

cells in blood vessels serving as a source for he-

ORIGIN OF THE SYSTEMIC

growth factor receptor b

matopoietic progenitors during a narrow develop-

LYMPHATIC VASCULATURE

PROX1 = prospero hemeobox1
VEGF = vascular endothelial

mental window before liver and bone marrow become

The lymphatic system includes lymphatic

growth factor

vessels, lymph nodes, and lymphoid organs

VEGFR3 = vascular endothelial

(13). Different from the circulatory blood

growth factor receptor

vessels, lymphatic vessels are structurally
blind-ended at their distal segments. These
blind ends form vessels that are designed to absorb
interstitial ﬂuid and immune cells and are called
lymphatic capillaries. These vessels converge onto
deeper lymphatic structures called collecting vessels
that are equipped with valves and a muscular wall
that promotes transport rather than absorption. Flow
in the lymphatic vasculature as a whole is unidirectional and is designed to drain extravascular ﬂuid,
macromolecules, and immune cells back into the
venous system to maintain interstitial ﬂuid balance.
The cells also transport absorbed lipids such as
chylomicron particles from the gut, and throughout
the body they function as a key structure in immune
surveillance (12,14). Despite much progress in all aspects of lymphatic vessel research, the organs from
which the lymphatic vascular system originate is still
under debate. As mentioned above, more than 100
years ago, lymphatic vessels were suggested to originate from lymph sacs by Florence Sabin (2). Sabin’s
early work was found consistent with results shown
later in mouse (15) and zebraﬁsh (16).
An

alternative

proposed

by

Huntington

and

the major hematopoietic tissues (22).
Only recently have data emerged regarding the
development and origins of lymphatic vasculature in
the heart (23). Lymphatic vessels emerge within the
developing heart at approximately embryonic day
12.5 (E12.5) and are ﬁrst visualized in association
with

the

ventral

outﬂow

tract.

At

E14.5,

LYVE1þPROX1 þVEGFR3 þ lymphatics sprout from the
sinus venosus and extend to cover the dorsal surface
of the left and right ventricles by E16.5. During late
gestation and early post-natal development, the
lymphatic vasculature expands to cover the entire
epicardial surface of heart (including dorsal and
ventral surfaces) and appears to mature by 2 weeks
of age. Beginning at E15.5, lymphatic vessels are
found in close proximity to developing coronary
veins and remain associated with venous vasculature
thereafter.

Although

interconnections

between

lymphatic and venous endothelial cells are observed
at early time points, these connections are lost as the
lymphatic vasculature matures. Intriguingly, lineage
tracing studies using Tie2-Cre and Pdgfr b-CreERT2
mice (carrying markers of vascular endothelial cells)
revealed that cardiac lymphatics were derived from
a mixed pool of progenitors including venous and
putative hemogenic endothelial origins.

FLOW PATTERNS OF CARDIAC LYMPH

McClure (17) hypothesized that peripheral lymphatics
lym-

The cardiac lymphatic vasculature was ﬁrst described

phangioblasts that gave rise to lymph sacs, suggesting

in the 17th century by Rudbeck, discussed in Bradham

that the origin of lymphatic vasculature is mixed. In

and Parker (24). Patek (25), publishing in 1939,

addition to the undisputed venous origin of many

revealed that the mammalian cardiac lymphatic

lymphatic vessels, recent evidence also has emerged

vasculature invested all layers of the heart: the sub-

to argue in favor of the concept that lymphatic

epicardium,

endothelial cells arise from other sources. In the

endocardium. The ﬂow and composition of cardiac

lumbar and dorsal dermal layer of mouse embryonic

lymph in dog were analyzed (26,27). That work

skin,

of

revealed that lymph ﬂow passed from the endocar-

lymphatic vessels are derived from nonvenous sour-

dium, after interstitial ﬂuid entered lymphatic capil-

ces (18). In zebraﬁsh, lymphatic vessels indeed arise

laries therein, to the epicardium where collecting

from the cardinal vein but derive from a subset of

lymphatic vessels with activity capable of propelling

arose

from

for

a

nonvenous

example,

source

approximately

through

one-third

the

myocardium,

and

the

sub-

specialized angioblasts therein, where Wnt5b serves

lymph ﬂow forward was observed (Figure 1A). Two

to induce lymphatic speciﬁcation (19). Until recently,

main collecting lymphatic vessels emerged, including

little has been deﬁned regarding the origins of the

one that runs along the left conal vein toward the

lymphatic vasculature during organogenesis. In the

left side of the pulmonary trunk and further upward

last few years, however, work from different groups

to the mediastinum to drain the right and left
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F I G U R E 1 Cardiac Lymphatic Drainage of an Adult Mouse Heart

(A) Cross-section of a heart demonstrates the direction of cardiac lymph drainage from endocardium, myocardium to epicardium (ﬂow
indicated by arrows). (B) Two major collecting vessels (green) on the epicardium then assist to drain lymph, originally derived from the
endocardium, from apex to base: one collecting vessel (left) runs along the left conal vein upward to the pulmonary trunk and mediastinum;
the other vessel (right) runs along the left cardiac vein and passes the coronary sinus and left atrium upward to the mediastinum.

ventricles and the other, which can be seen on the

remodeling in the injured heart. We trace the devel-

atrial surface, that runs along the left cardiac vein

opment of this area through its history.

(corresponding to the left marginal vein in humans),

Similar to other organs, the heart relies on cardiac

coronary sinus, and the left atrium upward to the

lymphatics to drain tissue ﬂuid in order to maintain

mediastinum

the

(Figure

1B)

(25,28,29).

Lymphatic

steady-state

interstitial

contractions

help

ﬂuid
to

equilibrium.

valves, operating similarly as venous valves, main-

Myocardial

propel

tain lymph ﬂow unidirectionally, with the greatest

lymphatic ﬂow. During diastole, when the heart

cardiac

number of valves appearing in the subepicardial col-

muscle relaxes, the ventricles ﬁll with blood, and

lecting lymphatic vessels. The ventricles are invested

the resultant increase in chamber pressure drives

with more lymphatic vessels than the atria (25).

the ﬂow of lymph from the subendocardial to the

Lymphatic vessels appear in the cardiac valves,

myocardial lymphatics. Subsequently, during systole,

potentially playing important roles. When cardiac

ventricular contraction supplies the necessary force

lymphatic drainage is impaired, the lymphatic capil-

to propel lymph from the myocardial to the sub-

lary network in the mitral valve appears increased

epicardial lymphatics (32). If ﬂow rate becomes

(30). Dogs and pigs have lymphatic vessels in both

reduced, increased myocardial interstitial edema,

atrioventricular valves, including tricuspid and mitral

which may contain necrotic products or toxins, oc-

valves, but humans have lymphatic vessels only in

curs, leading to increased interstitial pressure and to

the mitral valve (31).

compromised cardiac functions under both acute and
chronic conditions (33), due to increased ventricular

FUNCTION OF CARDIAC LYMPHATIC VESSELS:

stiffness in diastole and reduced cardiac performance

HISTORICAL AND NEW CONCEPTS

(33,34). Indeed, a very small change in interstitial
pressure in the heart can have extreme effects on

As delineated later, the concept that lymphatic

cardiac output (33–35).

function is critical to maintain cardiac function has

Osmotic forces are also at play in regulating ﬂuid

been clear for some time. However, only recently has

balance in the heart. Under normal conditions, the

the idea emerged that targeting the lymphatic

protein concentration of interstitial ﬂuid (and lymph)

vasculature might provide therapeutic beneﬁt. Spe-

is much lower than that of plasma. This imbalance

ciﬁcally, new evidence suggests that an expanded

creates a scenario that favors water movement back

lymphatic

lym-

into the bloodstream as it ﬂows toward higher protein

phangiogenesis, and improved lymphatic function

concentration. However, the impact of osmotic forces

augment

is diminished by the fact that smaller proteins are

vasculature,
tissue

repair

brought
and

about
prevent

by

adverse
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more osmotically active than larger proteins and that

and increase lymphatic drainage (47,48). However,

smaller proteins leak across inﬂamed vasculature,

whether lymphangiogenesis is necessary to support

resulting in increased interstitial protein concentra-

additional lymph ﬂow, as is often assumed, is un-

tion. As a consequence, osmotic forces that would

clear, as a reasonable counterargument can be made

normally drive ﬂuid movement from the interstitial

that the presence of lymphatic vessels at their basal

space into lymphatics and eventually the venous

density is more than sufﬁcient to cover the physio-

system are severely blunted and resultant tissue

logical and even pathological needs to cope with
problems of accumulated ﬂuid (13). In addition,

edema ensues (36).
Cardiac surgery often produces damage to the

lymphangiogenesis combined with the formation of

lymphatic vasculature that can lead to acute or occa-

tertiary lymphoid organs under certain circumstances

sionally chronic edema (37). Thus, experiments have

may sustain immune responses by facilitating the

been undertaken to describe the impact of surgical

transport of antigens as well as immune cells (13).

lymphatic

lymphatic

Inactivation of lymphatic vessel has been suggested

obstruction causes interstitial myocardial edema,

to serve as a novel therapy to reduce cardiac allograft

which in turn degrades ventricle performance, char-

rejection and arteriosclerosis (49).

obstruction.

Acute

cardiac

acterized by decreased contractility and increased

During the initial phase of edema after injury, M2

diastolic stiffness (38,39). Chronic lymphatic vessel

polarized macrophages, the major cell expressing

blockade, surgically induced for experimental pur-

vascular endothelial growth factor (VEGF)-C (50),

poses, leads to cardiac ﬁbrosis (40,41). Fibrosis in turn

regulate the formation of collateral lymphatic capil-

increases interstitial resistance and compounds the

laries. By contrast, accumulation of CD4 þ T cells

problem of ﬂuid ﬂow through the heart. This can be

in the later stage inhibits lymphangiogenesis and

due to collagen deposition (42) or possibly deposition

induces sclerosis of collecting lymphatics that leads

of other extracellular matrix components.

to interstitial ﬁbrosis and edema (51). Loss of CD4 þ T

There are still many outstanding questions in the

but not CD8þ T or CD25 þ T cells decreases lymphe-

ﬁeld to be answered, and it is a “black box” in un-

dema,

derstanding the detailed mechanisms of lymphatic

lymphangiogenesis (43), suggesting that lymphatic

drainage through the heart. Are lymphatic capillaries

growth is a highly coordinated process. Th2 T cells

in the myocardium understood at the cellular level?

and their cytokines interleukin (IL)-4 and IL-13

How do cardiac lymphatic capillaries take up ﬂuid

negatively regulate lymphangiogenesis and lym-

when pressures (>100 mm Hg) are generated every

phatic

second? Myocardial contractions help to propel car-

antibodies reduce lymphedema, suggesting the sig-

inﬂammation

function

and

(52);

ﬁbrosis

anti-IL-4

and

and

increases

anti-IL-13

diac lymphatic ﬂow, but is the lymphatic ﬂow solely

niﬁcant roles of Th2 T cells in the development of

dependent upon cardiac contraction? If not, how is

interstitial ﬁbrosis (52,53). In contrast, excessive

it regulated? Clearly, much remains to be learned,

generation of immature lymphatic vessels through

and future investigation is needed to answer those

Th1 and Th17 CD4þ inﬂammatory T cells can drive

questions.

the pathogenesis of lymphedema (54). In sum, skin

CONNECTIONS AMONG
INTERSTITIAL EDEMA, IMMUNE RESPONSES,
AND LYMPHANGIOGENESIS:
LESSONS LEARNED FROM THE SKIN
As indicated above, interstitial edema contributes
to tissue ﬁbrosis, which reinforces sluggish or rerouted interstitial ﬂow. In skin, lymphedema and
accompanying ﬁbrosis are also associated with
elevated inﬁltrated immune cells including macrophages and lymphocytes (43–45). At least in some

lymphedema induces inﬂammation that includes
recruited immune cells that in turn potentially cause
the formation of ﬁbrotic tissues. Targeting lymphangiogenesis may be a therapy to repair the skin
lesions and possibly those in other organs. However,
in order for this approach to move forward, it is critical to understand the mechanisms by which lymphangiogenesis improves, but sometimes worsens,
edema and in particular to understand if the main
purpose of inﬂammatory lymphangiogenesis is to
promote ﬂuid or cell clearance.

scenarios, the inhibition of cyclooxygenase 2 reduces

MYOCARDIAL ISCHEMIA-INDUCED TISSUE

the severity of lymphedema, suggesting the potential

FIBROSIS CAUSED BY IMMUNE CELLS
AFFECTS LYMPHATIC DRAINAGE

role of inﬂammation in maintaining lymphedema
(46). Stimulation of lymphangiogenesis, again at least
in some settings, can act effectively to inhibit chronic

Myocardial ischemia, the lack of blood supply to the

skin inﬂammation and immune cell accumulation

heart, causes rapid death of cardiac myocytes. At the
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same time, ﬂuid accumulates in the cardiac interstitial space, leading to the formation of myocardial
edema due to increased myocardial microvascular

C E NT R AL IL L U ST R AT IO N VEGF-C Treatment After Injury
Promotes Heart Function

permeability and the ﬁltration rate exceeding the
lymph ﬂow rate (33,55). Similar to skin lymphedema,
myocardial edema can trigger cardiac ﬁbrosis (33,56)
as shown by increased collagen synthesis including
types I and III by ﬁbroblasts (57,58). In the infarct
zone, inﬂammatory signals recruit neutrophils within
1 day and, thereafter, monocyte/macrophages arrive.
During the ﬁrst 3 days post-injury, Ly-6Chi monocytes
inﬁltrate and scavenge necrotic debris, and when
resolution begins, they differentiate into Ly-6C lo
macrophages that promote healing (59,60). During
this process, cytokines are produced and promote the
activation

of

collagen-secreting

ﬁbroblasts

(61),

including secretion of anti-inﬂammatory cytokines
such as IL-10 (62) and IL-13 (63). Although resultant
ﬁbrotic tissue can compensate for the loss of cardiomyocytes

and

provide

structural

support

following myocardial infarction to protect against
cardiac rupture, myocardial ﬁbrosis also has negative
consequences including hindering interstitial ﬂuid
drainage, impairing cardiac function, and contributing to adverse ventricular remodeling. Intriguingly,
lymphatic drainage through the myocardium can be
recovered by remodeling collateral circulation (64),
and this alleviates inﬂammatory responses orchestrated by chemokines and recruited leukocytes eli-

Huang, L.-H. et al. J Am Coll Cardiol Basic Trans Science. 2017;2(4):477–83.

cited following ischemic tissue injury (65).
Many concepts, including ﬂow and lymphangiogenic response to inﬂammation, are borrowed from
the lesson learned from the skin. Although those

Increased lymphangiogenesis of lymphatic capillaries and pre-collecting and collecting
vessels remodeling after treating the infarct heart with VEGF-C improves cardiac
functions in the infarcted heart. VEGF ¼ vascular endothelial growth factor.

concepts may apply to the heart as well, they are also
likely to be organ-speciﬁc mechanisms. Clearly, there
will be many new connections to be discovered as we
explore the lymphatic ﬁeld in full.

hypoxic state, and increases the scale of infarct
development (69).

LYMPHANGIOGENESIS AS A TARGET TO

Given the role of VEGF-C in wound repair to induce

PROMOTE HEART FUNCTION AFTER INJURY

lymphangiogenesis, its use therapeutically beneﬁts

After myocardial infarction, when much tissue is

lymphangiogenesis on cardiac function, VEGF-C

destroyed, the restoration of even the basal density of

therapy was applied after myocardial infarction and

lymphatic vessels is needed to restore interstitial

found to improve cardiac function post-myocardial

ﬂow. The basal lymphangiogenic response is quite

infarction

robust in humans (66,67) and also in animals (23,68).

inﬂammation (23,68). Although 1 of these 2 studies

The increases in lymphatic density are sustained

pointed solely to the impact of VEGF-C on increasing

during the healing phase, longer than that of blood

local lymphangiogenesis, Henri et al. (68) observed

vessels (66). Perhaps there is a prolonged need for

that local lymphangiogenesis was quite robust in the

lymphatic vessels during the healing phase, possibly

untreated cohort but that nonetheless VEGF-C ther-

lymphedema (70). To investigate the inﬂuence of

while

limiting

ﬁbrosis

and

lingering

to drain excessive proteins and ﬂuid. When lym-

apy was beneﬁcial. The study went on to ﬁnd that

phatics fail to remove accumulated ﬂuid, expansion

lymphatic capillary remodeling was far from the

of the interstitial ﬂuid compartment increases the

whole story, that indeed the major issue appeared to

diffusion

be adverse remodeling of the collecting lymphatics

distance

for

oxygen,

exacerbates

the
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that

negatively

impacted

ﬂuid

from

administration of VEGF-C in 2 different studies

infarcted and adjacent uninfarcted areas (68). Thus, it

transport

improved the rate and quality of cardiac healing in

is possible that, although lymphangiogenesis of the

experimental myocardial infarction in mice and rats.

small, blind-ended lymphatic capillaries garners

The positive outcome may be attributed to increased

attention most readily because this change is most

lymphangiogenesis of lymphatic capillaries in the

obvious (23), the most relevant therapeutic target

heart but may otherwise also relate to sustained

may be sustaining function of the deeper collecting

functionality of the deeper lymphatic collecting ves-

lymphatic vessels (68). Collectively, these 2 studies

sels. There is much work to be done in considering

raise a promising new approach to restoring the heart

lymphatic transport as a means to combat adverse

after myocardial infarction and highlight the poten-

events in the heart. The lymphatic vessels of the heart

tial that additional work on the lymphatic vasculature

deserve increased attention.

in the cardiac system may yield in treating dysfunction of the heart (Central Illustration).

CONCLUSIONS
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